Taken together with the lineage specificity of MCL1 as described by Dzhagalove et al. [37] it is conceivable that a pro-apoptotic effect of MCL1 in advanced MDS is expressed only in subset of cells, but does not interfere with increasing proliferation of the malignant clone. Here, MCL1 is linked to myelodysplastic syndrome.